Home » Stocks » ARAY

Accuray Incorporated (ARAY)

Stock Price: $4.76 USD 0.01 (0.21%)
Updated Jan 19, 2021 4:00 PM EST - Market closed
Market Cap 429.90M
Revenue (ttm) 378.68M
Net Income (ttm) 13.59M
Shares Out 91.19M
EPS (ttm) 0.15
PE Ratio 31.73
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 19
Last Price $4.76
Previous Close $4.75
Change ($) 0.01
Change (%) 0.21%
Day's Open 4.96
Day's Range 4.67 - 4.98
Day's Volume 928,316
52-Week Range 1.35 - 5.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 21 hours ago

SUNNYVALE, Calif., Jan. 19, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that data from a prospective, phase II trial of 338 women with low-risk breast cancer showe...

PRNewsWire - 1 week ago

SUNNYVALE, Calif., Jan. 8, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the second quarter of fiscal year 2021, ended December 31, 2020, after the...

Zacks Investment Research - 1 week ago

Accuray (ARAY) new innovative imaging solution is designed to provide cost effective and exceptional diagnostic quality image.

PRNewsWire - 2 weeks ago

SUNNYVALE, Calif., Jan. 6, 2021 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced its participation in the 39th J.P. Morgan Annual Healthcare Conference. Josh Levine, Preside...

PRNewsWire - 2 weeks ago

SUNNYVALE, Calif., Jan. 5, 2021 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (F...

InvestorPlace - 2 weeks ago

This year has been a remarkable one for cheap stocks, many of which have enjoyed contrarian upside. However, there are still more opportunities to be had for the intrepid speculator.

Other stocks mentioned: ABEV, ADT, AIV, DL, F, HVBTF, TK
Zacks Investment Research - 2 weeks ago

Accuray (ARAY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Investment Research - 3 weeks ago

Investor confidence is high on Accuray (ARAY) stock, courtesy of its solid prospects.

PRNewsWire - 1 month ago

SUNNYVALE, Calif., Dec. 3, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Jim Dennison, the comp...

Zacks Investment Research - 1 month ago

Does Accuray (ARAY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Investment Research - 1 month ago

Accuray's (ARAY) new deal with DHL Supply Chain will help in the delivery of advanced cancer treatment technology.

PRNewsWire - 2 months ago

SUNNYVALE, Calif. and WESTERVILLE, Ohio, Nov. 18, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) and DHL Supply Chain announced today they have entered into a global service parts lo...

PRNewsWire - 2 months ago

SUNNYVALE, Calif., Nov. 12, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed Jim Dennison as its senior vice president of global quality and regulatory...

PRNewsWire - 2 months ago

SUNNYVALE, Calif., Nov. 10, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that innovations in hardware and software solutions and clinical data presented at this yea...

Business Wire - 2 months ago

LONDON--(BUSINESS WIRE)-- #GlobalHeadandNeckCancerDiagnosticsMarket--The Head and Neck Cancer Diagnostics Market will grow by USD 3.41 bn during 2020-2024

Other stocks mentioned: CAJ
Zacks Investment Research - 2 months ago

Accuray (ARAY) registered growth in Service revenues in Q1.

Seeking Alpha - 2 months ago

Fiscal first quarter revenue was a little better than expected, and management did well on costs, achieving a modest profit where a modest loss had been expected. Orders were down, not surpris...

Seeking Alpha - 2 months ago

Accuray Incorporated (ARAY) CEO Josh Levine on Q1 2021 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Accuray (ARAY) delivered earnings and revenue surprises of 100.00% and 10.82%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks Investment Research - 2 months ago

Accuray (ARAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research - 3 months ago

Investors' confidence is high in the Accuray (ARAY) stock, thanks to its solid prospects.

PRNewsWire - 3 months ago

SUNNYVALE, Calif., Oct. 19, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today it has appointed Mike Leischer as its vice president and general manager, Americas (AMS) re...

Zacks Investment Research - 3 months ago

These three MedTech stocks are expected to grow post their Q3 earnings release.

Other stocks mentioned: CAH, DVA
Zacks Investment Research - 3 months ago

Let's keep a watch on potentially strong three MedTech stocks with respect to robotic-assisted surgery that have shown promise during the pandemic.

Other stocks mentioned: ISRG, SYK
InvestorPlace - 3 months ago

Robotics stocks represent innovation, technology and future profitability. For investors interested in those promises, click to read on.

Other stocks mentioned: ABB, AVAV, BRKS, ISRG, RTX, SYK
Zacks Investment Research - 3 months ago

The integration of Synchrony to Accuray's (ARAY) Radixact System will ensure that the hospital teams can efficiently deliver precise radiation doses to tumors.

PRNewsWire - 4 months ago

SUNNYVALE, Calif., Sept. 17, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that leading hospitals in Japan are using the Radixact® System with the Synchrony® Automat...

Zacks Investment Research - 4 months ago

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?

PRNewsWire - 4 months ago

SUNNYVALE, Calif., Sept. 10, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Joshua H.

PRNewsWire - 4 months ago

SUNNYVALE, Calif., Sept. 1, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the medical care team at University Hospital Città della Salute e della Scienza, in Tu...

Seeking Alpha - 5 months ago

Accuray Idling On The Runway Ahead Of A Significant Chinese Revenue Launch

Zacks Investment Research - 5 months ago

Accuray (ARAY) registered decline in Product and Service revenues in Q4

Seeking Alpha - 5 months ago

Accuray Incorporated (ARAY) CEO Joshua Levine on Q4 2020 Results - Earnings Call Transcript

Benzinga - 5 months ago

Shares of Accuray (NASDAQ:ARAY) rose 1.66% in after-market trading after the company reported Q4 results.

PRNewsWire - 5 months ago

SUNNYVALE, Calif., Aug. 13, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the fourth quarter and fiscal year ended June 30, 2020.

Benzinga - 5 months ago

On Thursday, August 13, Accuray (NASDAQ: ARAY) will release its latest earnings report.

Zacks Investment Research - 5 months ago

Accuray (ARAY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRNewsWire - 5 months ago

SUNNYVALE, Calif., July 22, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Anne B.

PRNewsWire - 6 months ago

SUNNYVALE, Calif., July 16, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the fourth quarter and the 2020 fiscal year, ended June 30, 2020 after th...

Zacks Investment Research - 6 months ago

In the face of the pandemic, the robotics-assisted surgery space continues to thrive on a slew of positive developments.

Other stocks mentioned: MDT, SYK
Zacks Investment Research - 7 months ago

Accuray's (ARAY) newly launched CyberKnife S7 System will enable clinicians to provide best possible care to their patients through new capabilities.

PRNewsWire - 7 months ago

SUNNYVALE, Calif., June 17, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the company has launched the CyberKnife® S7™ System, an innovative device combining speed, ...

Zacks Investment Research - 7 months ago

Investor confidence is high on Accuray (ARAY) stock, thanks to solid prospects.

Zacks Investment Research - 7 months ago

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research - 8 months ago

The coronavirus-led 'new normal' has altered several businesses. Here are three sectors that will see a boom in the near future.

Other stocks mentioned: APRN, AVAV, CRWD, DPZ, MSFT
Zacks Investment Research - 8 months ago

Since the coronavirus outbreak, robots have filled up several job vacancies caused by social distancing orders. Here are five robotics and related stocks investors should closely watch.

Other stocks mentioned: ABB, AVAV, NVDA, PTC
Zacks Investment Research - 8 months ago

Accuray (ARAY) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Zacks Investment Research - 8 months ago

Accuray (ARAY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Investment Research - 8 months ago

Accuray (ARAY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Seeking Alpha - 8 months ago

COVID-19 Saps Some Of Accuray's Momentum, But Execution Remains Strong

About ARAY

Accuray Incorporated designs, develops, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the body in the Americas, Europe, the Middle East, India, Japan, Africa, and rest of the Asia Pacific region. The company offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body. Its CyberKnife System automatically tracks, detects, and corrects for tumor and patient movement in real-time during ... [Read more...]

Industry
Medical Devices
IPO Date
Feb 8, 2007
CEO
Joshua Levine
Employees
932
Stock Exchange
NASDAQ
Ticker Symbol
ARAY
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for Accuray stock is "Strong Buy." The 12-month stock price forecast is 7.00, which is an increase of 47.06% from the latest price.

Price Target
$7.00
(47.06% upside)
Analyst Consensus: Strong Buy